Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Effects and mechanism of action of ligustrazine on isoprenaline-induced cardiomyocyte hypertrophy.

Ji XX, Song XL, Qian W, Yu XL, Zhu JY.

Cell Biochem Biophys. 2014 Dec;70(3):1513-8. doi: 10.1007/s12013-014-0086-2.

PMID:
25027096
2.
3.

Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.

Dai H, Jia G, Liu X, Liu Z, Wang H.

Environ Toxicol Pharmacol. 2014 Jul;38(1):263-71. doi: 10.1016/j.etap.2014.05.008. Epub 2014 Jun 13.

PMID:
24975447
4.

Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.

Li H, Shi S, Sun YH, Zhao YJ, Li QF, Li HZ, Wang R, Xu CQ.

Clin Exp Pharmacol Physiol. 2009 Mar;36(3):312-8. doi: 10.1111/j.1440-1681.2008.05064.x. Epub 2008 Oct 15.

PMID:
18986329
5.

Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.

Hiroyama M, Wang S, Aoyagi T, Oikawa R, Sanbe A, Takeo S, Tanoue A.

Eur J Pharmacol. 2007 Mar 22;559(2-3):89-97. Epub 2006 Dec 29.

PMID:
17275806
6.

The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1.

Feng XJ, Gao H, Gao S, Li Z, Li H, Lu J, Wang JJ, Huang XY, Liu M, Zou J, Ye JT, Liu PQ.

Br J Pharmacol. 2015 Jun;172(11):2852-63. doi: 10.1111/bph.13091. Epub 2015 Mar 26.

7.

Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.

Essick EE, Ouchi N, Wilson RM, Ohashi K, Ghobrial J, Shibata R, Pimentel DR, Sam F.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H984-93. doi: 10.1152/ajpheart.00428.2011. Epub 2011 Jun 10.

8.

Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis.

Yin W, Zhang P, Huang JH, Zhang QY, Fan R, Li J, Zhou JJ, Hu YZ, Guo HT, Zhang SM, Wang YM, Kaye AD, Gu CH, Liu JC, Cheng L, Cui Q, Yi DH, Pei JM.

Eur J Pharmacol. 2009 Apr 1;607(1-3):135-42. doi: 10.1016/j.ejphar.2009.01.050. Epub 2009 Feb 21.

PMID:
19233160
9.

Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.

Hayashi D, Kudoh S, Shiojima I, Zou Y, Harada K, Shimoyama M, Imai Y, Monzen K, Yamazaki T, Yazaki Y, Nagai R, Komuro I.

Biochem Biophys Res Commun. 2004 Sep 10;322(1):310-9.

PMID:
15313208
10.
11.

Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.

Tan X, Li J, Wang X, Chen N, Cai B, Wang G, Shan H, Dong D, Liu Y, Li X, Yang F, Li X, Zhang P, Li X, Yang B, Lu Y.

Int J Biol Sci. 2011 Apr 7;7(3):383-9.

12.

[Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].

Zhou DX, Liang QS, He XX, Zhan CY.

Zhongguo Zhong Yao Za Zhi. 2008 Apr;33(8):936-9. Chinese.

PMID:
18619357
13.

DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.

Lu YM, Shioda N, Han F, Kamata A, Shirasaki Y, Qin ZH, Fukunaga K.

Cardiovasc Ther. 2009 Spring;27(1):17-27. doi: 10.1111/j.1755-5922.2008.00068.x.

PMID:
19207476
14.

Leptin induces hypertrophy through activating the peroxisome proliferator-activated receptor α pathway in cultured neonatal rat cardiomyocytes.

Hou N, Luo MS, Liu SM, Zhang HN, Xiao Q, Sun P, Zhang GS, Luo JD, Chen MS.

Clin Exp Pharmacol Physiol. 2010 Nov;37(11):1087-95. doi: 10.1111/j.1440-1681.2010.05442.x.

PMID:
20738325
15.

[Atorvastatin attenuates parathyroid hormone 1-34 induced cardiomyocytes hypertrophy through downregulating K-Ras-ERK1/2 pathway].

Liu XG, Miao N, Sui MS, Mu SH, Zhao SL, Xie RJ.

Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Dec;40(12):1051-5. Chinese.

PMID:
23363723
16.

Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.

Lister K, Autelitano DJ, Jenkins A, Hannan RD, Sheppard KE.

Cardiovasc Res. 2006 Jun 1;70(3):555-65. Epub 2006 Feb 14.

PMID:
16533503
17.

Changes of c-fos and c-jun mRNA expression in angiotensin II-induced cardiomyocyte hypertrophy and effects of sodium tanshinone IIA sulfonate.

Zhou D, Liang Q, He X, Zhan C.

J Huazhong Univ Sci Technolog Med Sci. 2008 Oct;28(5):531-4. doi: 10.1007/s11596-008-0509-7. Epub 2008 Oct 10.

PMID:
18846332
18.

Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes.

Xu FP, Chen MS, Wang YZ, Yi Q, Lin SB, Chen AF, Luo JD.

Circulation. 2004 Sep 7;110(10):1269-75. Epub 2004 Aug 16.

19.

Exogenous hydrogen sulfide prevents cardiomyocyte apoptosis from cardiac hypertrophy induced by isoproterenol.

Lu F, Xing J, Zhang X, Dong S, Zhao Y, Wang L, Li H, Yang F, Xu C, Zhang W.

Mol Cell Biochem. 2013 Sep;381(1-2):41-50. doi: 10.1007/s11010-013-1686-7. Epub 2013 May 10.

PMID:
23660955
20.

The effect of intermedin on angiotensin II and endothelin-1 induced ventricular myocyte hypertrophy in neonatal rat.

Liu K, Deng X, Gong L, Chen X, Wang S, Chen H, Chen X, Amrit B, He S.

Clin Lab. 2013;59(5-6):589-96.

PMID:
23865358

Supplemental Content

Support Center